PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

CUSIP: 74019P207

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
+549,044
SEC-reported price per share
$3.81
Number of holders
51
Value change
-$4,075,765
Number of buys
30
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,643,000

Security key

74019P207

Report period

Q4 2024

Institutions

51

Top holders

10

Ownership snapshot

Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NOVARTIS PHARMA AG
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $6,322,131 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. has the largest disclosed position value at $6.32M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Disclosed position value Top 5
NOVARTIS PHARMA AG $4.59M
Janus Henderson Group Ltd. $6.32M
TANG CAPITAL MANAGEMENT LLC $5.59M
PERCEPTIVE ADVISORS LLC $3.82M
Aquilo Capital Management, LLC $3.42M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NOVARTIS PHARMA AG
3/4/5
10%+ Owner
—
denominator unverified
$4,590,753
12,407,440 shares
— 15 Jun 2022
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$6,322,131
702,069 shares
— 30 Sep 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$5,585,055
623,332 shares
— 30 Sep 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$3,819,585
426,293 shares
— 30 Sep 2024
Aquilo Capital Management, LLC
13F
Company
13F
—
denominator unverified
$3,420,955
381,803 shares
— 30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,365,117
263,964 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
51
Shares
3,859,340
Rows available
51
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q4 2025 Across Filers

Q4 2025 holders
67
Q4 2024 holders
51
Holder diff
-16
Investor Q4 2025 Shares Q4 2024 Shares Share Diff Share Chg % Q4 2025 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .